Our Pricing

Mounjaro Discount: How to Save on Your Weight Loss Treatment with Code WEIGHTLOSSNEW

Searching for a mounjaro discount code uk to reduce the cost of your weight loss treatment? At Cured Pharmacy, you can access genuine UK-licensed Mounjaro (tirzepatide) from £135.00 with transparent upfront pricing, free clinical consultation by UK prescribers, and discreet next-day delivery. Use code WEIGHTLOSSNEW to Save £135.00 on your first order.

How to Use Your Mounjaro Discount Code at Cured Pharmacy

Applying your mounjaro discount code uk at Cured Pharmacy is straightforward. Simply complete your free online consultation with our UK-registered clinical team, and once your prescription is approved, enter code WEIGHTLOSSNEW at checkout to receive £135.00 off your first order. This discount applies to all Mounjaro doses, from the 2.5mg starter pen through to the maintenance doses.

Unlike many online pharmacies that advertise low prices but add hidden consultation fees or delivery charges, Cured Pharmacy displays the full cost upfront. Your Mounjaro prescription starts from £135.00 includes the clinical assessment by a UK prescriber, and comes with free discreet delivery. There are no surprise charges at checkout, and your discount code is applied directly to the medication cost.

All Mounjaro prescriptions at Cured Pharmacy are subject to clinical approval by our UK-registered prescribers. The consultation takes under three minutes and covers your medical history, current medications, and weight loss goals to ensure Mounjaro is safe and appropriate for you.

Understanding Mounjaro Pricing in the UK Market

Mounjaro pricing varies significantly across UK pharmacies, with costs typically influenced by dose strength, supply chain arrangements, and pharmacy overheads. At Cured Pharmacy, our pricing starts from £135.00 for genuine UK-licensed Mounjaro KwikPens, with the exact cost determined by your prescribed dose following clinical assessment.

The tirzepatide molecule in Mounjaro represents a significant advancement in weight management pharmacotherapy. As the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management, it activates two complementary hormonal pathways rather than one [1]. This dual mechanism contributes to the substantial weight reductions observed in clinical trials.

When comparing mounjaro price comparison uk options, it's essential to verify that you're receiving genuine medication from a GPhC-registered pharmacy. Cured Pharmacy (GPhC 9012511) sources all Mounjaro pens directly through licensed UK wholesalers, ensuring authenticity and proper cold-chain storage. Superintendent pharmacist Tarun Kumar (GPhC 2233073) personally oversees our dispensing protocols to maintain the highest safety standards.

Why Mounjaro Costs More Than Older Weight Loss Treatments

Mounjaro's higher cost compared to treatments like orlistat reflects its novel dual-agonist mechanism and the extensive clinical development programme behind it. The SURPASS clinical trial series demonstrated average weight reductions of up to 22.5% over 72 weeks with the 15mg maintenance dose — significantly greater than single-pathway GLP-1 treatments [1][2]. This enhanced efficacy comes from simultaneous activation of both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, which work synergistically to reduce appetite and improve metabolic function.

Clinical Evidence: How Mounjaro Delivers Weight Loss Results

The SURPASS-3 trial, a 72-week randomised controlled study, demonstrated that participants taking tirzepatide 15mg achieved an average body weight reduction of 22.5% from baseline, compared to 2.4% in the placebo group [1]. These results represent some of the most substantial weight losses observed with any pharmacological intervention currently licensed in the UK.

Mounjaro works by mimicking two naturally occurring incretin hormones. GLP-1 activation slows gastric emptying and enhances satiety signals to the brain, whilst GIP activation appears to complement these effects through additional metabolic pathways [1]. In clinical practice, patients typically report reduced hunger between meals and earlier feelings of fullness during eating — physiological changes that support sustainable calorie reduction.

The medication is administered as a once-weekly subcutaneous injection using a pre-filled KwikPen device. Treatment begins with a 2.5mg dose for four weeks to minimise gastrointestinal side effects, then increases gradually to reach an effective maintenance dose, typically between 5mg and 15mg depending on individual response and tolerability [3]. Your UK prescriber will determine the appropriate titration schedule based on your clinical assessment.

Expected Timeline for Weight Loss Results

Most patients begin noticing appetite reduction within the first two weeks of starting Mounjaro, though significant weight loss typically becomes evident after 8-12 weeks once the dose has been titrated upward [1]. In the SURPASS trials, weight loss continued progressively throughout the 72-week study period, with the most substantial reductions occurring between weeks 20 and 52 [2]. This gradual, sustained weight loss is considered more physiologically appropriate than rapid drops, as it allows time for metabolic adaptation and behaviour modification.

Mounjaro vs Other Weight Loss Treatments: Making the Right Choice

UK patients now have access to several prescription weight loss medications, each with distinct mechanisms, efficacy profiles, and cost considerations. Mounjaro represents the newest option, whilst treatments like Wegovy (semaglutide) and Saxenda (liraglutide) are established GLP-1 receptor agonists with substantial clinical evidence. Orlistat-based treatments work through an entirely different mechanism by blocking dietary fat absorption.

Wegovy contains semaglutide, a single GLP-1 receptor agonist that demonstrated average weight loss of 14.9% over 68 weeks in the STEP-1 trial [4]. Whilst this is clinically significant, it's notably lower than the 22.5% average seen with the highest Mounjaro dose in comparable trial populations [1][2]. Both medications require once-weekly injection and share similar side effect profiles, predominantly gastrointestinal symptoms during dose escalation.

Saxenda (liraglutide) requires daily injection rather than weekly administration, which some patients find less convenient. Orlistat-based treatments like Xenical and Alli work by preventing approximately 30% of dietary fat absorption, leading to more modest weight loss of 5-10% when combined with dietary modification [5]. These oral medications suit patients who prefer to avoid injections but are prepared for potential gastrointestinal side effects related to unabsorbed fat.

Which Treatment Your Prescriber May Recommend

Your UK prescriber will consider multiple factors when recommending a weight loss treatment, including your BMI, previous weight loss attempts, medical history, and personal preferences regarding injection frequency. Patients with a BMI over 35 (or over 30 with weight-related health conditions) may be suitable for injectable GLP-1 treatments like Mounjaro or Wegovy, subject to clinical assessment. Those with contraindications to GLP-1 medications, such as personal or family history of medullary thyroid carcinoma, would be directed toward alternative options like orlistat.

Maximising Your Mounjaro Discount and Long-Term Value

Beyond the initial £135.00 discount with code WEIGHTLOSSNEW, maximising value from your Mounjaro treatment involves understanding the full treatment pathway. Most patients require 6-12 months of treatment to achieve their target weight loss, with some continuing longer-term for weight maintenance [1]. At Cured Pharmacy, we offer consistent competitive pricing across all doses, so your monthly cost remains predictable as you progress through the titration schedule.

The medication requires proper storage between 2°C and 8°C before first use, and can then be kept at room temperature (not exceeding 30°C) for up to 21 days [3]. Each KwikPen contains four weeks' supply at your prescribed dose, delivered in temperature-controlled packaging to maintain efficacy. Proper storage and administration technique ensure you receive the full therapeutic benefit from each pen.

Weight loss medications work most effectively when combined with dietary modification and increased physical activity. The appetite suppression from Mounjaro makes it easier to adhere to a reduced-calorie diet, but sustainable results require behaviour change alongside pharmacotherapy. Your prescriber may recommend follow-up consultations to monitor progress and adjust your treatment plan as needed.

Starting Your Mounjaro Treatment at Cured Pharmacy

Beginning treatment at Cured Pharmacy involves a straightforward three-step process. First, complete our free online consultation, which takes under three minutes and covers your medical history, current medications, weight loss goals, and any contraindications. Our UK-registered prescribers review every consultation individually — this isn't an automated approval system.

If Mounjaro is deemed clinically appropriate for you, your prescription is issued and sent to our dispensary where superintendent pharmacist Tarun Kumar and his team prepare your medication. We dispense only genuine UK-licensed Mounjaro KwikPens sourced through authorised wholesalers, never grey-market imports. Your medication is packaged discreetly and dispatched via next-day delivery in temperature-controlled packaging.

Your first prescription will typically be for the 2.5mg starter dose, taken once weekly for four weeks. After this initial period, you'll need a follow-up consultation to progress to the next dose level. This gradual titration minimises side effects and allows your body to adjust to the medication. Remember to apply code WEIGHTLOSSNEW at checkout to receive your £135.00 discount on your first order.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., Stefanski, A., & SURMOUNT-1 Investigators. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Ludvik, B., Giorgino, F., Jódar, E., Frias, J. P., Fernández Landó, L., Brown, K., Bray, R., & Rodríguez, Á. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583–598. https://doi.org/10.1016/S0140-6736(21)01443-4
3. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14269
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., Kushner, R. F., & STEP 1 Study Group. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
5. Rucker, D., Padwal, R., Li, S. K., Curioni, C., & Lau, D. C. (2007). Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ, 335(7631), 1194–1199. https://doi.org/10.1136/bmj.39385.413113.25

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary and are not guaranteed.